ASP Isotopes
ASPI
6 hedge funds and large institutions have $2.77M invested in ASP Isotopes in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
3,583% more capital invested
Capital invested by funds: $75.3K → $2.77M (+$2.7M)
100% more funds holding
Funds holding: 3 → 6 (+3)
9.32% more ownership
Funds ownership: 0.14% → 9.45% (+9.3%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$4.96M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$43.7K |
| 3 |
VF
Virtu Financial
New York
|
+$16.6K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$475 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$3.02K |
ASPI Hedge Fund Activity: Q1 2023 in Review
6 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in ASP Isotopes (ASPI) for Q1 2023, worth a combined $2.77M — up 3,583% from $75.3K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ASPI positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $4.96M. The largest seller was Millennium Management, cutting an estimated $3.02K.
- 6 institutional investors held ASP Isotopes (ASPI) as of Q1 2023, up from 3 in Q4 2022.
- Funds reported $2.77M of ASP Isotopes stock for Q1 2023, up 3,583% quarter-over-quarter.
- 3 funds opened new ASP Isotopes positions in Q1 2023 and 0 closed out, a net change of +3 holders.
- The largest ASP Isotopes buyer in Q1 2023 was Armistice Capital, an estimated $4.96M added.
- The largest ASP Isotopes seller in Q1 2023 was Millennium Management, an estimated $3.02K sold.
Based on aggregated 13F filings for Q1 2023.